(Total Views: 378)
Posted On: 03/08/2021 10:33:56 PM
Post# of 145248
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
The bad news for LL was that the improvement in SOC has so dramatically helped severe covid-19 patients, preventing them from advancing to critical and then possibly dying.
So our market for cv19 LL seems clearly to be critical, longhaulers and also mild/moderate. Our m/m data was compelling and should have earned an EUA.
So our market for cv19 LL seems clearly to be critical, longhaulers and also mild/moderate. Our m/m data was compelling and should have earned an EUA.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)